Remedy, a dermatologist-developed skin care brand, has raised US$20m in funding.
The Series A funding round was led by L Catterton, a private equity firm created by LVMH, Groupe Arnault and Catterton.
Existing investor Norwest and new investor Sonoma Brands Capital, both US-based venture and growth equity investment firms, also participated.
The investment will support the next phase of growth for Remedy, including advancing clinical research and expanding its pipeline of dermatologist-developed products.
The company also plans to deepen its capabilities across formulation, testing and consumer education as it continues building a scaled dermocosmetic platform.
"We seek to partner with exceptional founders building brands that will redefine categories, and we believe Remedy is uniquely modernising dermatological skin care," said Tehmina Haider, Partner at L Catterton.
"As both a clinician and a consumer educator, [Remedy founder] Dr Muneeb Shah has built a portfolio of simple, effective and accessibly priced products that leverage advanced ingredient technologies to address real patient needs.
“And that is what will define the next generation of dermocosmetics.
“The brand's rapid growth reflects deep consumer demand for affordable, clinically-grounded skin care, and we are thrilled to partner with the Remedy team on their next chapter."
Remedy was founded in March 2024 and is said to have reported significant growth across all online channels, including its D2C website, Amazon and TikTok Shop.
The business also claimed to have seen “breakout success” in US retailer Target following its December 2025 nationwide launch.
Lisa Wu, Partner at Norwest, added: “Since our initial investment, Remedy has scaled rapidly across all channels and built consumer trust by delivering what today’s skin care consumers are looking for: efficacy, simplicity and accessibility.
“We are thrilled to double down on our partnership and continue supporting their mission to make dermatological expertise and treatments accessible to all.”
Shah, founder and CEO of Remedy, continued: “For years, I saw patients who were doing everything right but still struggling to find products that delivered meaningful results without irritation or unnecessary complexity.
“Remedy was created to modernise dermatologist-developed skin care.”
Related content:
- L Catterton and Chinese beauty group Mao Geping agree strategic partnership
- L Catterton snaps up minority stake in French perfume house Ex Nihilo
- L Catterton to create Brazil’s ‘largest beauty retail platform’
- LVMH to sell Marc Jacobs after 30 years
- LVMH CEO Bernard Arnault’s annual pay revealed
- LVMH sales sink on disappointing beauty performance offset by Sephora